D.E. Shaw & Co
INGN icon

D.E. Shaw & Co’s Inogen INGN Stock Holding History

D.E. Shaw & Co’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$288K Buy
+46,643
New +$288K ﹤0.01% 4087
2025
Q1 		– Sell
-73,282
Closed -$672K – 4472
2024
Q4 		$672K Sell
73,282
-77,489
-51% -$725K ﹤0.01% 3440
2024
Q3 		$1.46M Sell
150,771
-4,715
-3% -$49.5K ﹤0.01% 2955
2024
Q2 		$1.26M Buy
155,486
+23,742
+18% +$184K ﹤0.01% 3024
2024
Q1 		$1.06M Sell
131,744
-179,984
-58% -$1.27M ﹤0.01% 3056
2023
Q4 		$1.71M Sell
311,728
-26,771
-8% -$141K ﹤0.01% 2794
2023
Q3 		$1.77M Buy
338,499
+36,094
+12% +$257K ﹤0.01% 2674
2023
Q2 		$3.49M Buy
302,405
+238,030
+370% +$2.81M ﹤0.01% 2155
2023
Q1 		$803K Buy
64,375
+52,567
+445% +$1.01M ﹤0.01% 3306
2022
Q4 		$233K Buy
11,808
+1,210
+11% +$26.1K ﹤0.01% 4184
2022
Q3 		$257K Buy
+10,598
New +$293K ﹤0.01% 4363
2022
Q1 		– Sell
-6,018
Closed -$205K – 5724
2021
Q4 		$205K Buy
6,018
+343
+6% +$12.5K ﹤0.01% 4870
2021
Q3 		$245K Sell
5,675
-20,322
-78% -$1.25M ﹤0.01% 4473
2021
Q2 		$1.69M Buy
25,997
+14,438
+125% +$914K ﹤0.01% 3102
2021
Q1 		$607K Sell
11,559
-12,033
-51% -$601K ﹤0.01% 3412
2020
Q4 		$1.05M Sell
23,592
-23,286
-50% -$804K ﹤0.01% 2986
2020
Q3 		$1.36M Sell
46,878
-39,931
-46% -$1.25M ﹤0.01% 2653
2020
Q2 		$3.08M Sell
86,809
-144,661
-62% -$6.1M ﹤0.01% 2061
2020
Q1 		$12M Sell
231,470
-133,193
-37% -$6.4M 0.02% 893
2019
Q4 		$24.9M Buy
364,663
+319,513
+708% +$20M 0.03% 700
2019
Q3 		$2.16M Buy
45,150
+25,136
+126% +$1.31M ﹤0.01% 2280
2019
Q2 		$1.34M Sell
20,014
-31,271
-61% -$2.38M ﹤0.01% 2503
2019
Q1 		$4.89M Sell
51,285
-52,019
-50% -$6.49M 0.01% 1563
2018
Q4 		$12.8M Buy
+103,304
New +$17M 0.02% 933
2015
Q2 		– Sell
-18,588
Closed -$595K – 3800
2015
Q1 		$595K Buy
+18,588
New +$600K ﹤0.01% 2948

Other funds holding INGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co's INGN Position: Q1 2026 in Review

D.E. Shaw & Co opened a new position in Inogen (INGN) in Q1 2026: 46,643 shares worth $288K. The stake represents ﹤0.01% of the portfolio and ranks #4087 among its holdings. This is a return to the name: D.E. Shaw & Co previously reported a position in INGN as recently as Q4 2024.

D.E. Shaw & Co first reported a position in INGN in Q1 2015 and has held it in 25 quarters since. The position peaked at $24.9M in Q4 2019. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.

  • D.E. Shaw & Co held 46,643 shares of Inogen worth $288K as of Q1 2026.
  • Inogen was a new D.E. Shaw & Co position in Q1 2026.
  • Inogen made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4087 holding.
  • D.E. Shaw & Co first reported a position in Inogen in Q1 2015 and has held it in 25 quarters since.
  • D.E. Shaw & Co's Inogen position peaked at $24.9M in Q4 2019.
  • 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.